The levels of exosomal CAV1 in patient plasma were significantly higher in ovarian cancer patients with FIGO stages I/II, low grade (1/2) than FIGO stages III/IV disease and high grade (3/4) (both P < 0.01; Figure 2D, 2F). This evidence concerns the gene CAV1 and ovarian carcinoma.